Monoclonal antibodies in oncology: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 May 2024

  • curprev 19:3419:34, 29 May 2024‎ Ai talk contribs‎ 7,302 bytes +7,302‎ Created page with "== Introduction == Monoclonal antibodies (mAbs) have revolutionized the field of oncology, offering targeted therapies that have significantly improved the prognosis for many cancer patients. These antibodies are engineered to bind to specific antigens found on the surface of cancer cells, thereby interfering with the growth and spread of tumors. This article delves into the development, mechanisms, applications, and future prospects of monoclonal antibodies in oncology..."
Retrieved from "https://canonica.ai/page/Monoclonal_antibodies_in_oncology"